ISSN: 1745-7580
+44-77-2385-9429
Ebtekar Masoumeh, Amir Kalvanagh Parisa, Soleimanjahi Hoorieh, Matloobi Zahra and Kokaei Parviz
Tarbiat Modares University, Iran
Semnan University of Medical Sciences, Iran
Scientific Tracks Abstracts: J Immunome Res
Statement of the Problem: During the last 15 years since the discovery of type III human interferons (IFN-�»1, IFN-�»2 and IFN-�»3), numerous biological activity of these new interferon family has been introduced by researchers. Furthermore, several studies have showed that the encapsulation of plasmid DNA with nanoparticle result to protection of plasmid DNA against DNase enzyme and increasing gene delivery to the cells. So we decided to encapsulate plasmid DNA encoding IFN-�»1 with PLGA in order to compare encapsulated and naked form of plasmid DNA encoding IFN-�»1 in the future researches. Methodology & Theoretical Orientation: At first, the expression and bioactivity of pIFN-�»1 was investigated in vitro by sandwich ELISA and CPER assay, respectively. Then, pIFN-�»1 was encapsulated in PLGA nanoparticles using double emulsion-solvent evaporation method and characterized in terms of size, zeta potential and polydispersity index (DLS), morphology (SEM) and encapsulation efficiency and release kinetics. Uptake of nanoparticles by RAW264.7 macrophages was also studied by fluorescent microscope. Findings: IFN-�»1 expressed in HEK293T was confirmed by sandwich ELISA and IFN-�±2b was able to protect HEP2 cells against VSV infection. Developed nanoparticles were spherical in shape with a mean diameter of 381 nm (PdI: 0.279), encapsulation efficiency was 75�±5% and a zeta potential of -3.35�±7.75 mV was observed. Release assay in vitro showed that the plasmid DNA could be sustainably released from nanoparticles. Not only the successful expression of plasmid DNA encoding GFP revealed that nanoparticle could be engulfed by macrophages, but it also represented that the integrity of plasmid has been intact during encapsulation process. Conclusion & Significance: Given the results in order to figure out the other new functions of this molecule or re-evaluation of previous investigations, using prepared and characterized nanoparticles instead of naked plasmids seems to be practically feasible.
Ebtekar Masoumeh has been working as a Faculty Member at Tarbiat Modares University in Tehran. Currently, she is an Associate Professor of Immunology, and has supervised many PhD and MSc students. She has expertise in cytokines, viral immunology, HIV vaccines, aging, immunology of the nervous system and psychoneuroimmunology.
Email: ebtekarm@modares.ac.ir